Protara Therapeutics Inc. sell stratec
Start price
28.03.19
/
50%
€20.73
Target price
29.03.19
€18.04
Performance (%)
0.00%
End price
29.03.19
€18.04
Summary
This prediction ended on 29.03.19 with a price of €18.04. The SELL prediction by stratec closed unchanged from the start price. stratec has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Protara Therapeutics Inc. | -25.581% | -25.581% | -9.220% | -90.085% |
iShares Core DAX® | -0.205% | 2.528% | 16.157% | 18.725% |
iShares Nasdaq 100 | 1.613% | 4.733% | 30.626% | 56.133% |
iShares Nikkei 225® | -0.740% | 0.396% | 9.039% | 5.948% |
iShares S&P 500 | 0.267% | 2.720% | 26.333% | 47.720% |
Comments by stratec for this prediction
In the thread Proteon Therapeutics Inc diskutieren
Proteon's vonapanitase flunks second late-stage study
A Phase 3 clinical trial, PATENCY-2, evaluating Proteon Therapeutics' (NASDAQ:PRTO)
(Zielkurs erreicht)